US Physical Therapy Beats on EPS But GAAP Results Lag
Mar 8th 2013 10:39AM
Updated Mar 8th 2013 12:05PM
US Physical Therapy (NYS: USPH) reported earnings on March 7. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), US Physical Therapy met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded. GAAP earnings per share dropped significantly.
Gross margins dropped, operating margins increased, net margins shrank.
US Physical Therapy logged revenue of $62.7 million. The six analysts polled by S&P Capital IQ wanted to see net sales of $62.3 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.34. The six earnings estimates compiled by S&P Capital IQ forecast $0.33 per share. GAAP EPS of $0.34 for Q4 were 51% lower than the prior-year quarter's $0.69 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 24.6%, 180 basis points worse than the prior-year quarter. Operating margin was 12.9%, 20 basis points better than the prior-year quarter. Net margin was 6.4%, 720 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $66.2 million. On the bottom line, the average EPS estimate is $0.40.
Next year's average estimate for revenue is $263.9 million. The average EPS estimate is $1.59.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 240 members out of 244 rating the stock outperform, and four members rating it underperform. Among 76 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 75 give US Physical Therapy a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on US Physical Therapy is outperform, with an average price target of $30.83.
Is US Physical Therapy the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add US Physical Therapy to My Watchlist.
The article US Physical Therapy Beats on EPS But GAAP Results Lag originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.